Cetylpyridinium chloride mouthwash ingredient voted Category I for safety, efficacy.
This article was originally published in The Tan Sheet
Executive Summary
CETYLPYRIDINIUM CHLORIDE MOUTHWASH INGREDIENT DEEMED CATEGORY I for plaque and gingivitis treatment by FDA's Dental Products Panel Plaque Subcommittee at its May 8-9 meeting in Bethesda, Md. The eight-member subcommittee unanimously voted that the ingredient, contained in Procter & Gamble's Scope, J.B. Williams' Cepacol and other products, including Plus+White Anti-Stain Oral Rinse (CCA Industries), Swish (Unico) and Tech 2000 (Care-Tech Labs), should be classified as safe and effective for the treatment of both plaque and gingivitis.
You may also be interested in...
Cetylpyridinium Nasal Spray Status As Category I Oral Antiseptic Requested
Inclusion of a nasal spray containing .05% cetylpyridinium chloride in FDA's tentative final monograph for Oral Antiseptic Drug Products is requested by SinoFresh Research Labs in a March 24 citizen petition
Cetylpyridinium Nasal Spray Status As Category I Oral Antiseptic Requested
Inclusion of a nasal spray containing .05% cetylpyridinium chloride in FDA's tentative final monograph for Oral Antiseptic Drug Products is requested by SinoFresh Research Labs in a March 24 citizen petition
Cetylpyridinium Nasal Spray Status As Category I Oral Antiseptic Requested
Inclusion of a nasal spray containing .05% cetylpyridinium chloride in FDA's tentative final monograph for Oral Antiseptic Drug Products is requested by SinoFresh Research Labs in a March 24 citizen petition